Where pretreated oral cancer cell line OC2 and KB cells with various concentrations (1, 10, and 100 mM) of berberine (1) have shown dose dependent PGE2 inhibitory activity via suppressing the COX-2 expression. This evidence concerns the gene PTGS2 and lip and oral cavity carcinoma.